Medication info

Empagliflozin 25 mg Tablet

Prescription medicationTabletOral
Ingredient · strength
Empagliflozin›25mg / 1 tablet
Manufacturer / importer
Shinpoong Pharmaceutical Co., Ltd.
Appearance
Light yellow, biconvex oval film-coated tablet
Packaging
10 tablets/box (10 tablets/PTP x 1), 30 tablets/box (10 tablets/PTP x 3), 30 tablets/bottle
Approval status
Active

MFDS item code 202102111 · Approved 2021.03.05

Summary

Main use
Improvement of glycemic control in adults with type 2 diabetes
Who takes it
Adults
Adult dose
The recommended dose of this medicine is 10 mg once daily, whether used as monotherapy or as add-on combination therapy with other glucose-lowering agents, such as insulin. If 10 mg of this medicine is well tolerated and additional glycemic control is needed, the dose may be increased to 25 mg once daily. When this medicine is coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia. This medicine may be taken with or without food. Swallow the tablet whole. If you miss a dose, take it as soon as you remember. Do not take double the dose in one day. No dose adjustment is necessary in patients with mild renal impairment. Treatment with this medicine should not be initiated in patients with an estimated glomerular filtration rate (eGFR) < 60 ml/min/1.73m2 [or CrCl < 60 ml/min]. In patients who tolerate this medicine well and whose glomerular filtration rate remains < 60ml/min/1.73m2 [or CrCl < 60 ml/min], the dose should be adjusted to or maintained at 10 mg once daily. This medicine should be discontinued if the glomerular filtration rate decreases to < 45 ml/min/1.73m2 [or CrCl < 45 ml/min]. Do not use this medicine in patients with end-stage renal disease (ESRD) or those on dialysis, because efficacy is not expected. No dose adjustment is necessary in patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment, as it has not been studied in this population. No dose adjustment based on age is necessary. Renal function and the risk of volume depletion should be considered in patients aged 75 years or older. Initiation of treatment with this medicine is not recommended in patients aged 85 years or older because clinical experience is limited.

Ingredients

Manufacturer
Shinpoong Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in adults with type 2 diabetes

  • Difficulty controlling blood glucose
  • inability to control blood glucose
  • type 2 diabetes
View approved original text

This medication is used as a treatment to help control blood glucose levels in adults with type 2 diabetes, acting as an adjunct to dietary management and exercise. It can be used as monotherapy but is often administered in combination with metformin for patients who have not previously been treated with diabetes medications or find it difficult to control blood glucose levels alone. Additionally, it can be added when sufficient blood glucose control is not achieved with metformin alone. It can also be used alongside pioglitazone, sulfonylureas, insulin, or the DPP-4 inhibitor linagliptin when blood glucose control is inadequate. Special caution is needed for patients with type 2 diabetes who have cardiovascular diseases, and consulting related specialist information is advisable. This medication is used to improve blood glucose control in patients with type 2 diabetes.

How to take

Adult dose

The recommended dose of this medicine is 10 mg once daily, whether used as monotherapy or as add-on combination therapy with other glucose-lowering agents, such as insulin. If 10 mg of this medicine is well tolerated and additional glycemic control is needed, the dose may be increased to 25 mg once daily. When this medicine is coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia. This medicine may be taken with or without food. Swallow the tablet whole. If you miss a dose, take it as soon as you remember. Do not take double the dose in one day. No dose adjustment is necessary in patients with mild renal impairment. Treatment with this medicine should not be initiated in patients with an estimated glomerular filtration rate (eGFR) < 60 ml/min/1.73m2 [or CrCl < 60 ml/min]. In patients who tolerate this medicine well and whose glomerular filtration rate remains < 60ml/min/1.73m2 [or CrCl < 60 ml/min], the dose should be adjusted to or maintained at 10 mg once daily. This medicine should be discontinued if the glomerular filtration rate decreases to < 45 ml/min/1.73m2 [or CrCl < 45 ml/min]. Do not use this medicine in patients with end-stage renal disease (ESRD) or those on dialysis, because efficacy is not expected. No dose adjustment is necessary in patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment, as it has not been studied in this population. No dose adjustment based on age is necessary. Renal function and the risk of volume depletion should be considered in patients aged 75 years or older. Initiation of treatment with this medicine is not recommended in patients aged 85 years or older because clinical experience is limited.

Precautions

This medication should not be administered to certain patients. First, individuals allergic to the active ingredient or any of the excipients should not take this medication. It is also not suitable for patients with type 1 diabetes or diabetic ketoacidosis. Patients with significantly reduced kidney function, with a glomerular filtration rate (GFR) of less than 30 mL/min/1.73m2, those with end-stage renal disease, or patients undergoing dialysis should also not use this medication. Furthermore, since this medication contains lactose, individuals with lactose intolerance, galactose intolerance, or inherited lactase deficiency should not take it. Caution is advised when using this medication in patients with slightly reduced kidney function. In particular, it is advised not to initiate this medication in patients with a GFR of less than 60 mL/min/1.73m2, and if they are currently taking it, the dosage may need to be reduced or discontinued. In patients with end-stage renal disease or those on dialysis, the efficacy of this medication is not expected, thus it should not be used. Patients with heart failure, particularly those with mild to moderate conditions, should use this medication cautiously, and it is not recommended for patients with severe heart failure. When used in combination with insulin or sulfonylureas, there is a risk of hypoglycemia, hence caution is needed and the dosages of these medications may need to be reduced. Possible side effects while taking this medication include hypoglycemia, urinary tract infections, genital infections, increased urination, decreased fluid volume, etc. Particularly, hypoglycemia may occur more frequently when combined with insulin or sulfonylureas, so vigilance is advised. Additionally, rare but serious adverse reactions such as ketoacidosis, pyelonephritis, and perineal necrosis have been reported, so immediate consultation with healthcare professionals is necessary upon the appearance of symptoms. This medication can affect the body’s fluid status, so elderly individuals, those with hypotension, and patients with cardiovascular diseases should be especially cautious. Pregnant women are advised not to take this medication, and it should be discontinued if pregnancy is confirmed. Breastfeeding women should also discontinue breastfeeding while on this medication. Its safety and efficacy have not been established in children under 18 years of age, thus it should not be used in this population. No specific toxic symptoms have been reported in cases of overdose, however, appropriate treatment is necessary depending on clinical conditions. This medication should be kept out of the reach of children, and it should not be transferred to other containers. Caution is required when driving or operating machinery due to the risk of hypoglycemia, especially when taken with insulin or other hypoglycemic agents. When monitoring blood glucose levels while taking this medication, the 1,5-AG test may be unreliable, so other methods are recommended. Finally, regular kidney function tests should be conducted while on this medication, and if symptoms of infection or abnormal signs appear, immediate consultation with healthcare professionals is necessary.

Side effects

  • Hypoglycemia
  • vulvovaginitis
  • balanitis
  • other genital infections
  • increased urination
  • urinary tract infection
  • decreased fluid volume
  • dehydration
  • hypotension
  • decreased blood volume
Show 223 more
  • orthostatic hypotension
  • syncope
  • dysuria
  • interstitial nephritis
  • thirst
  • increased serum lipids
  • increased blood creatinine
  • decreased glomerular filtration rate
  • increased hematocrit
  • ketoacidosis
  • urosepsis
  • pyelonephritis
  • rash
  • urticaria
  • angioedema
  • perineal necrosis
  • diarrhea
  • nausea
  • gastric ulcer
  • colitis
  • vomiting
  • ischemic colitis
  • gastrointestinal bleeding
  • soft tissue infection
  • appendiceal abscess
  • appendicitis
  • meningitis
  • chronic otitis media
  • peritonsillar abscess
  • pneumonia
  • pulmonary tuberculosis
  • acute pyelonephritis
  • sepsis
  • subcutaneous abscess
  • tubo-ovarian abscess
  • vestibular neuritis
  • headache
  • cerebral infarction
  • intracranial aneurysm
  • fever
  • vascular stent stenosis
  • vascular stent thrombosis
  • ureteral stone disease
  • acute kidney injury
  • cervicitis
  • hyperglycemia
  • hyponatremia
  • back pain
  • glaucoma
  • pathological myopia
  • retinal detachment
  • retinal vein occlusion
  • macular retinal detachment
  • limb injury
  • road traffic accident
  • splenic injury
  • sternum fracture
  • angina pectoris
  • Prinzmetal angina
  • coronary artery disease
  • deep vein thrombosis
  • benign tumor of the ampulla of Vater
  • benign ovarian tumor
  • bladder cancer
  • gastric cancer
  • pancreatic adenocarcinoma
  • colorectal cancer
  • thyroid cancer
  • uterine leiomyoma
  • acute cholecystitis
  • autoimmune hepatitis
  • cholelithiasis
  • upper abdominal pain
  • dental caries
  • erosive gastritis
  • abdominal discomfort
  • dry mouth
  • gastroesophageal reflux disease
  • abdominal distension
  • anal bleeding
  • chronic gastritis
  • enteritis
  • bloating
  • gastric polyp
  • gingival edema
  • passage of blood in stool
  • hemorrhoids
  • pancreatic cyst
  • rectal pain
  • toothache
  • upper respiratory tract infection
  • bronchitis
  • chronic sinusitis
  • gastroenteritis
  • Helicobacter infection
  • periodontitis
  • chronic tonsillitis
  • conjunctivitis
  • influenza
  • laryngitis
  • complete white nail syndrome
  • dental abscess
  • nasopharyngitis
  • positional vertigo
  • sensory loss
  • perceptual abnormality
  • amnesia
  • carotid artery stenosis
  • diabetic neuropathy
  • facial paralysis
  • memory impairment
  • neuralgia
  • Parkinson's syndrome
  • polyneuropathy
  • sensory disturbance
  • drowsiness
  • CNS-origin vertigo
  • fatigue
  • peripheral edema
  • facial edema
  • peripheral swelling
  • chills
  • strange sensation
  • edema
  • pain
  • pain at the puncture site
  • weight gain
  • abnormal electrocardiogram
  • decreased hemoglobin
  • increased hemoglobin
  • positive Helicobacter test
  • positive urine red blood cells
  • chronic kidney disease
  • hematuria
  • hypertonic bladder
  • renal mass
  • urinary retention
  • urinary pain
  • abnormal urination
  • benign prostatic hyperplasia
  • erectile dysfunction
  • atrophic vaginitis
  • scrotal pain
  • sexual dysfunction
  • vaginal discharge
  • hypoglycemia
  • decreased appetite
  • obesity
  • dyslipidemia
  • vitamin D deficiency
  • dermoid cyst
  • seborrheic dermatitis
  • atopic dermatitis
  • nummular eczema
  • heat rash
  • sebaceous gland hyperplasia
  • lumbar spinal stenosis
  • myalgia
  • musculoskeletal chest pain
  • arthralgia
  • cervical stenosis
  • fibromyalgia
  • flank pain
  • fracture pain
  • muscle weakness
  • osteoarthritis
  • osteoporosis
  • rotator cuff syndrome
  • astigmatism
  • cataract
  • allergic conjunctivitis
  • blurred vision
  • corneal erosion
  • eye discomfort
  • eye congestion
  • eyelid swelling
  • visual impairment
  • vitreous floaters
  • vitreous hemorrhage
  • nosebleed
  • asthma
  • age-related dyspnea
  • wet cough
  • allergic rhinitis
  • residual sputum
  • skin laceration
  • bruise
  • rib fracture
  • concussion
  • corneal abrasion
  • falls
  • hand fracture
  • iliotibial band syndrome
  • open eye injury
  • pelvic fracture
  • palpitations
  • tachycardia
  • arteriosclerosis
  • diabetic vascular complications
  • peripheral artery obstructive disease
  • anxiety
  • depression
  • sleep disorders
  • acute cholecystitis
  • hepatitis
  • otalgia
  • positional dizziness
  • anemia
  • lymphadenopathy
  • hypothyroidism
  • thyroid nodules
  • constipation
  • vulvar pruritus
  • genital pruritus
  • dyslipidemia
  • diabetes
  • diabetic retinopathy
  • dry eyes
  • cough
  • dyspnea
  • unstable angina
  • hypertension
  • insomnia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent exposure to air and moisture. It is best to maintain storage temperatures between 1 and 30 degrees Celsius at room temperature.

Appearance and packaging

Appearance

Light yellow, biconvex oval film-coated tablet

Package unit

10 tablets/box (10 tablets/PTP x 1), 30 tablets/box (10 tablets/PTP x 3), 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.